New resource: Meningococcal B vaccination – a guide for healthcare providers 

This new NCIRS resource provides a general guide for healthcare providers to facilitate effective communication about meningococcal B (Men B) vaccination. The resource has a focus on Aboriginal and Torres Strait Islander children.

Under the National Immunisation Program changes that came into effect from 1 July 2020, MenB vaccine (Bexsero) is now funded for all Aboriginal and Torres Strait Islander children from 2 months of age. A catch-up program is also available for Aboriginal and Torres Strait Islander children aged <2 years (i.e. up to 23 months) until June 2023.

The incidence of MenB disease is 4 times higher in Aboriginal and Torres Strait Islander children aged <2 years than non-Indigenous children of the same age. The vaccine is funded to reduce the burden of disease in young Aboriginal and Torres Strait Islander children.

MenB vaccine is also funded for all people of any age with certain specified medical risk conditions which put them at higher risk of MenB disease. 

Meningococcal disease is a serious illness that can cause disability and death. Vaccination is a safe and effective way to protect against this disease.

Access the resource here